Shionogi To Buy Texas Biotech IntraBio In $2B Deal
Japanese drugmaker Shionogi & Co. said Monday it has agreed to acquire Austin, Texas-based biotech IntraBio Inc. for $2 billion, with Cleary Gottlieb Steen & Hamilton LLP advising Shionogi and Kirkland &...To view the full article, register now.
Already a subscriber? Click here to view full article